About T-cell surface glycoprotein CD5
T-cell surface glycoprotein CD5 (CD5) is a protein
from Homo sapiens identified by UniProt accession
P06127, 495 residues long.
MolForge cross-references it against 0 known binders and
604 disease associations.
Target properties
| Protein name | T-cell surface glycoprotein CD5 |
| UniProt accession | P06127 |
| Gene | CD5 |
| Organism | Homo sapiens |
| Length | 495 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (604)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.27
- gut microbiome measurement · score 0.27
- eosinophil count · score 0.27
- eosinophil percentage of leukocytes · score 0.22
- systolic blood pressure · score 0.20
- smoking status measurement · score 0.20
- multiple sclerosis · score 0.16
- adolescent idiopathic scoliosis · score 0.12
- diffuse large B-cell lymphoma · score 0.12
- chronic lymphocytic leukemia · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P06127-F1 | alphafold | PREDICTED | 73.36 | — |
Amino-acid sequence (495 residues)
MPMGSLQPLA TLYLLGMLVA SCLGRLSWYD PDFQARLTRS NSKCQGQLEV YLKDGWHMVC SQSWGRSSKQ WEDPSQASKV CQRLNCGVPL SLGPFLVTYT PQSSIICYGQ LGSFSNCSHS RNDMCHSLGL TCLEPQKTTP PTTRPPPTTT PEPTAPPRLQ LVAQSGGQHC AGVVEFYSGS LGGTISYEAQ DKTQDLENFL CNNLQCGSFL KHLPETEAGR AQDPGEPREH QPLPIQWKIQ NSSCTSLEHC FRKIKPQKSG RVLALLCSGF QPKVQSRLVG GSSICEGTVE VRQGAQWAAL CDSSSARSSL RWEEVCREQQ CGSVNSYRVL DAGDPTSRGL FCPHQKLSQC HELWERNSYC KKVFVTCQDP NPAGLAAGTV ASIILALVLL VVLLVVCGPL AYKKLVKKFR QKKQRQWIGP TGMNQNMSFH RNHTATVRSH AENPTASHVD NEYSQPPRNS HLSAYPALEG ALHRSSMQPD NSSDSDYDLH GAQRL
Explore T-cell surface glycoprotein CD5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets